These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9421334)

  • 1. The failure of a once-daily vancomycin dosing regimen in patients with normal renal function.
    Marik PE
    J Antimicrob Chemother; 1997 Nov; 40(5):745-6. PubMed ID: 9421334
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of once-daily vancomycin for staphylococcal endocarditis.
    Marik PE
    Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.
    Sirbu BD; Soriano MM; Manzo C; Lum J; Gerding DN; Johnson S
    Clin Infect Dis; 2017 Oct; 65(8):1396-1399. PubMed ID: 28591789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
    Psevdos G; Gonzalez E; Sharp V
    AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial dosing of vancomycin in critically ill patients.
    Kees MG; Vögeler S; Hilpert JW
    Int J Antimicrob Agents; 2011 Jul; 38(1):91-2. PubMed ID: 21546217
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML; Cole E; Wolfsdorf J
    J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin: over 50 years later and still a work in progress.
    Rybak MJ; Rotschafer JC; Rodvold KA
    Pharmacotherapy; 2013 Dec; 33(12):1253-5. PubMed ID: 24302197
    [No Abstract]   [Full Text] [Related]  

  • 9. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
    Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
    J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
    Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
    Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
    Morrill HJ; Caffrey AR; Noh E; LaPlante KL
    Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing and monitoring 2 years after the guidelines.
    Lomaestro BM
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):657-67. PubMed ID: 21692671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.
    Aradhyula S; Manian FA; Hafidh SA; Bhutto SS; Alpert MA
    South Med J; 2006 May; 99(5):518-20. PubMed ID: 16711316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loading dose of vancomycin: is there a consensus view?].
    Descloux E; Mohammedi I; Robert D
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):755. PubMed ID: 15324969
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicin.
    Chadwick DH; Agarwal S; Vora BJ; Hair M; McKewan A; Gokal R
    J Nephrol; 1999; 12(5):318-21. PubMed ID: 10630696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    Crowther GS; Chilton CH; Longshaw C; Todhunter SL; Ewin D; Vernon J; Karas A; Wilcox MH
    J Antimicrob Chemother; 2016 Apr; 71(4):986-91. PubMed ID: 26755495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
    Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
    Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
    Kadambari S; Heath PT; Sharland M; Lewis S; Nichols A; Turner MA
    J Antimicrob Chemother; 2011 Nov; 66(11):2647-50. PubMed ID: 21862473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin administration and monitoring reappraisal.
    Saunders NJ
    J Antimicrob Chemother; 1995 Aug; 36(2):279-82. PubMed ID: 8522457
    [No Abstract]   [Full Text] [Related]  

  • 20. Vancomycin for meticillin-resistant Staphylococcus aureus (MRSA) infections in the Intensive Care Unit: the sunset boulevard of a gold standard?
    Pagani L
    Int J Antimicrob Agents; 2011 Aug; 38(2):187-8. PubMed ID: 21636255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.